| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.90B | +15.7% |
| Cost of Revenue | $25.96B | +2.8% |
| R&D Expense | $38.48B | +8.9% |
| SG&A Expense | $11.41B | -3.5% |
| Operating Income | $46.75B | +61.5% |
| Interest Expense | $446.0M | +141.1% |
| Pre-tax Income | $47.43B | +64.6% |
| Income Tax | $8.33B | +48.2% |
| Net Income | $39.10B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.86B | +185.1% |
| Short-term Investments | $23.54B | -9.7% |
| Accounts Receivable | $16.17B | +20.1% |
| Current Assets | $85.36B | +43.4% |
| Total Assets | $229.62B | +23.6% |
| Current Liabilities | $31.96B | +18.3% |
| Long-term Debt | $18.39B | +85.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $71.11B | +40.9% |
| Capital Expenditures | $27.27B | -13.3% |
| Investing Cash Flow | -$24.50B | +15.4% |
| Financing Cash Flow | -$19.50B | +11.9% |
| Free Cash Flow | $43.85B | +130.2% |
| +68.5% |
| EPS (Basic) | $15.19 | +76.0% |
| EPS (Diluted) | $14.87 | +73.1% |
| Total Liabilities |
| $76.45B |
| +27.4% |
| Stockholders' Equity | $153.17B | +21.8% |